Targeting of BRM sensitizes BRG1-mutant lung cancer cell lines to radiotherapy. – Logos Biosystems | Advanced Imaging Solutions for Research Excellence

Products

< Back

Customer Reviews

< Back

Customer Reviews

Photo Testimonials

Researcher Highlight

Resources

< Back

Videos / Webinars

Support

< Back

About Us

< Back

Targeting of BRM sensitizes BRG1-mutant lung cancer cell lines to radiotherapy.

2019-03-25

2019. Zernickel E, Sak A, Riaz A, Klein D, Groneberg M, Stuschke M. Molecular Cancer Therapeutics 18(3): 656-666.